Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Imunon Inc has a consensus price target of $21.25 based on the ratings of 4 analysts. The high is $29 issued by D. Boral Capital on March 24, 2025. The low is $12 issued by HC Wainwright & Co. on December 19, 2024. The 3 most-recent analyst ratings were released by D. Boral Capital on March 24, 2025, February 27, 2025, and February 19, 2025, respectively. With an average price target of $29 between D. Boral Capital, there's an implied 2800.00% upside for Imunon Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/24/2025 | Buy Now | 2800% | D. Boral Capital | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
02/27/2025 | Buy Now | 2800% | D. Boral Capital | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
02/19/2025 | Buy Now | 2800% | D. Boral Capital | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
01/24/2025 | Buy Now | 2800% | D. Boral Capital | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
12/19/2024 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
12/19/2024 | Buy Now | 2800% | D. Boral Capital | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
12/11/2024 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
12/10/2024 | Buy Now | 2800% | D. Boral Capital | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
11/25/2024 | Buy Now | 2800% | D. Boral Capital | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
11/11/2024 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | $14 → $12 | Maintains | Buy | Get Alert |
11/07/2024 | Buy Now | 2800% | EF Hutton | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
10/31/2024 | Buy Now | 2800% | EF Hutton | Jason Kolbert48% | $29 → $29 | Maintains | Buy | Get Alert |
09/23/2024 | Buy Now | 2800% | EF Hutton | Jason Kolbert48% | → $29 | Initiates | → Buy | Get Alert |
08/15/2024 | Buy Now | 1300% | HC Wainwright & Co. | Emily Bodnar39% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
08/05/2024 | Buy Now | 1300% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $14 | Maintains | Buy | Get Alert |
05/14/2024 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | $13 → $12 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 1200% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $13 | Maintains | Buy | Get Alert |
03/13/2024 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
09/15/2023 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | → $12 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | → $12 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 1100% | HC Wainwright & Co. | Emily Bodnar39% | → $12 | Reiterates | → Buy | Get Alert |
10/13/2022 | Buy Now | 1400% | Alliance Global Partners | James Molloy30% | → $15 | Initiates | → Buy | Get Alert |
The latest price target for Imunon (NASDAQ:IMNN) was reported by D. Boral Capital on March 24, 2025. The analyst firm set a price target for $29.00 expecting IMNN to rise to within 12 months (a possible 2421.74% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for Imunon (NASDAQ:IMNN) was provided by D. Boral Capital, and Imunon maintained their buy rating.
There is no last upgrade for Imunon
There is no last downgrade for Imunon.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imunon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imunon was filed on March 24, 2025 so you should expect the next rating to be made available sometime around March 24, 2026.
While ratings are subjective and will change, the latest Imunon (IMNN) rating was a maintained with a price target of $29.00 to $29.00. The current price Imunon (IMNN) is trading at is $1.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.